Navigation Links
TriLink BioTechnologies, Inc. Launches New Website and OligoBuilder(R)
Date:5/12/2010

SAN DIEGO, May 12 /PRNewswire/ -- TriLink BioTechnologies, Inc. (TriLink), a key manufacturer of high quality oligonucleotides and nucleoside triphosphates, announced the launch of its new website and OligoBuilder® online oligonucleotide ordering system. TriLink's in-house marketing and design team utilized extensive user feedback and survey results to design a customer-centric website. The site renovation embodies TriLink's commitment to their customers.

The website, trilinkbiotech.com, now features a streamlined design to improve navigation, more content and new tools. Key additions include:

  • A new OligoBuilder® online oligonucleotide ordering system
  • All new eCommerce system for purchasing all modified nucleotides and DNA synthesis reagents
  • Ask An Expert blog complete with extensive FAQs section
  • Improved information library including a literature corner, bibliography and publications list

The new improved OligoBuilder® prices very highly modified small scale constructs on the spot improving the order experience and reducing overall turn around time. Due to the complexity of the modified oligonucleotides typically ordered, automatic pricing on most constructs was not previously available.

"We are proud to announce the launch of our new site and OligoBuilder® as a big step towards a stronger online presence," said TriLink CEO, Dr. Richard Hogrefe.

TriLink plans to continue working with their customers to provide more online tools, services and information.

About TriLink

TriLink manufactures custom oligonucleotides, modified nucleoside triphosphates and CleanAmp™ PCR products for the diagnostic and OEM markets. In addition, custom chemistry, contract research services and ISO/QSR compliant cGMP production facilities are offered. TriLink's solutions help advance drug discovery and biomedical research. Founded in 1996, TriLink is a privately held firm based in San Diego, California and employs approximately 75 scientists and other professionals. For more information about the firm and products, call 858-546-0004, email info@trilinkbiotech.com, or visit our web site at www.trilinkbiotech.com.


'/>"/>
SOURCE TriLink BioTechnologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. TriLink BioTechnologies, Inc. Relaunches Oligonucleotide Radiolabeling Services
2. TriLink BioTechnologies to Sponsor GIVING HUNGER THE BLUES, a Benefit Concert to Help Alleviate Hunger in San Diego County
3. Glycos Biotechnologies, Inc. Selected to Present at Alternative Energy Innovations 2009
4. Solos Endoscopy, Inc. Sells Ovascope and Mastascope Product Line to Lifeline Biotechnologies, Inc.
5. Microchip Biotechnologies, Inc. Awarded Contract Under US Army Commercialization Pilot Program
6. Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc.
7. Microchip Biotechnologies, Inc. Enters Into License Arrangement With GE Healthcare for Fundamental Microfluidic Patents
8. Millennium Biotechnologies, Inc. Signs Marketing and Distribution Agreement with Ferring Pharmaceuticals
9. Microchip Biotechnologies, Inc. Collaborating With Stanford University on Developing a Front End Microfluidic-Based Sample Preparation System for Pyrosequencing Platforms
10. Raven biotechnologies, inc. and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies
11. Millennium Biotechnologies, Inc. Launches SURGEX(TM) the First Scientifically Validated Sports Nutritional Product Created from the Medical Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit ... 7th and 8th June 2018 in San Francisco, CA. The Summit brings together current ... several distinguished CEOs, board directors and government officials from around the world to address ...
(Date:10/11/2017)... ... 2017 , ... Disappearing forests and increased emissions are the main causes of ... year. Especially those living in larger cities are affected by air pollution related diseases. ... most pollution-affected countries globally - decided to take action. , “I knew I had ...
(Date:10/10/2017)... Los Angeles, CA (PRWEB) , ... ... ... Pharmaceuticals, Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) ... all uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed ...
(Date:10/10/2017)... CRUZ, Calif. , Oct. 10, 2017 ... grant from the NIH to develop RealSeq®-SC (Single Cell), ... kit for profiling small RNAs (including microRNAs) from single ... Analysis Program highlights the need to accelerate development of ... "New techniques for measuring ...
Breaking Biology Technology:
(Date:4/11/2017)... DUBLIN , Apr. 11, 2017 Research ... Tracking Market 2017-2021" report to their offering. ... The global eye tracking market to grow at ... The report, Global Eye Tracking Market 2017-2021, has been prepared based ... report covers the market landscape and its growth prospects over the ...
(Date:4/5/2017)... -- Today HYPR Corp. , leading innovator in ... the HYPR platform is officially FIDO® Certified . ... that empowers biometric authentication across Fortune 500 enterprises and ... 15 million users across the financial services industry, however ... suites and physical access represent a growing portion of ...
(Date:3/30/2017)... , March 30, 2017 The research ... system for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D ... a new realm of speed and accuracy for use in identification, ... an affordable cost. ... ...
Breaking Biology News(10 mins):